Episode 80: Unicorn growth spurts, Amgen's future, & mice on Twitter
Who puts horns on unicorns? How do graying drug companies find green ideas? And what would mice tweet?
19 Sep 201929min
Episode 79: Pelosi's drug pricing plan, Moderna's mRNA drug factories, and a DIY disease cure
House Speaker Nancy Pelosi’s drug pricing plan is aggressive, but is it viable? Can Moderna turn cells into tiny drug-making factories? What’s it like to cure your own rare disease?
12 Sep 201919min
Episode 78: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue
What separates good drug companies from mediocre ones? Have biohackers sold out? And who's going to run the FDA?
5 Sep 201924min
Episode 77: Purdue, J&J, and a week of big opioid crisis news
What does Dr. Richard Sackler sound like? When is $500 million a small amount of money? And what will come of the drug companies at the heart of the opioid crisis?
29 Aug 201918min
Episode 76: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech
How should you talk to friends about rejection? Can Facebook actually improve the lives of children? And how's biotech doing in China?
22 Aug 201923min
Episode 75: The serious side of spit kits, how BiTEs leave a mark, & Sarepta's sluggish study
Is anything too weighty to be explained over the internet? Can a new spin on old technology outfox CAR-T? And does that controversial drug even work?
15 Aug 201929min
Episode 74: Novartis and the no good, very bad week
Why did Novartis (NVS) keep its scandal to itself? Who knew what and when? And is there such thing as too much Peloton time?
8 Aug 201919min
Episode 73: Canadian pills, corporate jets, & racists with spit kits
Will Canada run out of drugs? Should you ever read your partner's diary? And what does Pepe the Frog know about genomics?
1 Aug 201923min
